Updates on Uterine Artery Embolization
- PMID: 29628616
- PMCID: PMC5886769
- DOI: 10.1055/s-0038-1636521
Updates on Uterine Artery Embolization
Abstract
Uterine fibroids (leiomyomas) are the most common benign neoplasm of the female pelvis and have a lifetime prevalence exceeding 80% among African American women and approaching 70% among Caucasian women. Approximately 50% of women with fibroids experience symptoms which may include menorrhagia that may result in anemia, bulk symptoms with bladder and bowel dysfunction and abdominal protrusion, dysmenorrhea, and infertility. Hysterectomy remains the most common treatment option for fibroids and concerns have been raised about the overuse of this procedure. Uterine artery embolization (UAE) is now a well-established uterine preserving and minimally invasive therapy for symptomatic fibroids. Since its introduction, strong evidence for safety and efficacy of UAE has been generated with low rates of complications. This review will discuss UAE for the management of symptomatic uterine fibroids with special focus on emerging technical approaches and novel periprocedural patient care.
Keywords: embolization; fibroid; interventional radiology; menorrhagia; uterus.
References
-
- Stewart E A. Clinical practice. Uterine fibroids. N Engl J Med. 2015;372(17):1646–1655. - PubMed
-
- Silberzweig J E, Powell D K, Matsumoto A H, Spies J B. Management of uterine fibroids: a focus on uterine-sparing interventional techniques. Radiology. 2016;280(03):675–692. - PubMed
-
- Ravina J H, Herbreteau D, Ciraru-Vigneron Net al. Arterial embolisation to treat uterine myomata Lancet 1995346(8976):671–672. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
